Introduction {#sec1}
============

Parental imprinting is a form of epigenetic regulation by which genes are expressed from only one of the two parental alleles. In humans, loss of imprinting is associated with several diseases (e.g., Prader-Willi/Angelman syndromes) and malignancies (e.g., Wilm's tumor) ([@bib34]). The generation of mouse embryos containing only maternal (parthenogenetic) or paternal (androgenetic) alleles ([@bib19]; [@bib30]; [@bib31]) demonstrated the importance of imprinting for restricting asexual form of reproduction in placental mammals. Parthenogenesis may occur naturally in humans resulting in parthenogenetic ovarian teratomas. We have recently generated human-parthenogenetic-induced pluripotent stem cells (PgHiPSCs) by reprogramming of parthenogenetic ovarian teratomas ([@bib29]). Studying the gene expression of PgHiPSCs enabled us to identify novel paternally expressed genes (PEGs), and to study the developmental potential of these cells ([@bib29]). Differential marking of DNA methylation in the gametes is considered the hallmark mechanism controlling parental imprinting as it establishes germline DMRs (gDMRs), which are then maintained throughout the life of the embryo ([@bib25]; [@bib26]; [@bib28]). In the past few years, global surveys of imprinted DMRs in the mouse were reported ([@bib13]; [@bib14]; [@bib25]; [@bib27]), and recently DNA methylation analysis at single-base resolution, performed on reciprocal crosses of inbred-mice, identified dozens of novel DMRs ([@bib33]). In humans, however, due to ethical and technical limitations, only few low-resolution surveys were achieved thus far ([@bib6]). Moreover, the vast majority of DMRs in humans were identified by association with certain diseases or by sharing synteny with mouse DMRs. In this study, we aimed to perform a comprehensive analysis of imprinted DMRs in humans. We thus analyzed global DNA methylation of our PgHiPSCs and their parental fibroblasts by reduced representation bisulfite sequencing (RRBS) ([@bib10]; [@bib20]) and compared the methylation signature to that of a large panel of human embryonic stem cells (HESCs) and induced pluripotent stem cells (HiPSCs) ([@bib5]).

Results {#sec2}
=======

Analysis of Known Imprinted DMRs in Human Pluripotent Stem Cells {#sec2.1}
----------------------------------------------------------------

Parthenogenetic cells lack the paternal allele and are therefore expected to exhibit differential methylation patterns in imprinted DMRs when compared to normal biparental cells. Notably, comparing the DNA methylation signature can equally identify maternal DMRs (mDMRs), which are expected to show hypermethylation and paternal DMRs (pDMRs), which will exhibit hypomethylation when compared to normal cells ([Figure S1](#app2){ref-type="sec"}A available online). Recently, a similar approach was used to identify epigenetic variation of known imprinted DMRs ([@bib22]). To carry out a comprehensive study of DNA methylation in PgHiPSCs, we performed RRBS on four iPSC lines derived from two independent parthenogenetic teratoma cell lines, which were shown to exhibit a complete homozygote diploid genome ([@bib29]). Similar analysis was performed on the parental parthenogenetic teratoma cell lines. The data were then filtered and evaluated through bioinformatic analysis ([@bib4]), yielding high-coverage reads and reproducible results ([Figure S1](#app2){ref-type="sec"}B). We next compared the global DNA methylation profiles of PgHiPSCs, their parental cells with previously published data sets including 20 samples of HESCs, 12 samples of HiPSCs, and six samples of normal human fibroblasts ([@bib5]). This large data set of undifferentiated and differentiated cells has previously enabled the identification of epigenetic changes associated with X inactivation ([@bib21]) and was now utilized as a reference for a comprehensive study of epigenetic changes associated with parental imprinting in the different cell types. Unsupervised hierarchical clustering demonstrated that the undifferentiated pluripotent stem cells share a distinct epigenetic signature, which distinguishes them from mature parthenogenetic and normal somatic cells ([Figure S2](#app2){ref-type="sec"}A). We then analyzed the status of methylation of known imprinted DMRs ([Table 1](#tbl1){ref-type="table"}). Since loss of imprinting is associated with disease and malignancies, perturbations in imprinted DMRs may affect the therapeutic potential of HESCs. We therefore studied the heterogeneity of known imprinted DMRs in HESCs ([Figure 1](#fig1){ref-type="fig"}A). While most of the DMRs examined maintain stable hemimethylation values in wild-type samples (average methylation calls \[AMCs\] between 0.3 and 0.7), few DMRs (*PEG3*, *DIRAS3*, and *ZDBF2*) show more variable values in the pluripotent stem cells. This effect does not seem to correlate with culture passaging as the variability was evident even in low-passage HESCs ([Figure S2](#app2){ref-type="sec"}B). We next asked whether reprogramming of somatic cells to pluripotency affects the methylation levels of known DMRs. In agreement with our previous study on the stability of imprinted genes in HiPSCs ([@bib24]), the vast majority of DMRs maintain hemimethylation values, thus demonstrating striking similarities between HiPSCs and HESCs ([Figure 1](#fig1){ref-type="fig"}B**)**.

However, the three DMRs that exhibit the highest levels of variation in HESCs show loss of imprinting in HiPSCs and are consistently hypermethylated in these cells. This can be due to loss of imprinting in the parental fibroblasts, or, alternatively, imply that these DMRs are more susceptible to aberrant methylation during reprogramming. To distinguish between the two options, we examined the methylation levels of these DMRs in the parental somatic cells ([Figure S2](#app2){ref-type="sec"}C). Our results show that, while *PEG3* and *DIRAS3* DMRs exhibit loss of imprinting already in the parental cells, the *ZDBF2* DMR may be prone to perturbations that are due to the reprogramming process. Studying the methylation levels of DMRs in 16-day-old embryoid bodies (EBs), that were differentiated from HESCs, further emphasized that in vitro differentiation resulted in loss of the DMR in *DIRAS3* and *PEG3* sites ([Figure 1](#fig1){ref-type="fig"}C). We next compared the methylation levels of known DMRs between PgHiPSCs and HESCs. Unlike normal HiPSCs, the parthenogenetic HiPSCs can be distinguished from HESCs in virtually all imprinted DMRs examined ([Figure 1](#fig1){ref-type="fig"}D), and are either hypermethylated (AMC \>0.7) or hypomethylated (AMC \<0.3) in comparison to the hemimethylation state of the HESCs (AMC between 0.3 and 0.7). For example, the two well-studied imprinted DMR loci *KCNQ1OT* and *IGF2-H19* are either hypermethylated (mDMR, [Figure 1](#fig1){ref-type="fig"}E) or hypomethylated (pDMR, [Figure 1](#fig1){ref-type="fig"}F) in the PgHiPSCs, in comparison to being hemimethylated in the biparental cells.

Genome-wide Search for Novel Imprinted DMRs {#sec2.2}
-------------------------------------------

In order to identify novel imprinted DMRs throughout the genome, we first verified the integrity of our data by studying the methylation values of previously discovered DMRs. Out of 22 well-established imprinted DMRs, 18 are either hypermethylated or hypomethylated in the PgHiPSCs in comparison to HESCs (methylation difference \>0.15). Of the four known DMRs that could not be identified in our analysis, three also show loss of imprinting in the normal PSCs (e.g., *PEG3*), and one lost the imprint upon reprogramming of the parthenogenetic somatic cells into PgHiPSCs (e.g., *GNAS*, [Figures S2](#app2){ref-type="sec"}D and S2E, respectively). We next searched for hemimethylation regions in both HESCs and HiPSCs and compared them to the methylation status in PgHiPSCs. In addition, we focused on regions in which the difference in DNA methylation levels between PgHiPSCs and HESCs was greater than 0.2 (see [Experimental Procedures](#sec4){ref-type="sec"}). Aberrant changes in DNA methylation, arising during the establishment of HiPSCs, are a major concern when aiming to identify epigenetic differences between normal and parthenogenetic PSCs. We therefore studied multiple HiPSC lines, derived from different sources. Furthermore, we filtered out regions of recurrent aberrant reprogramming, which were previously mapped in iPS cell lines derived from distinct tissues ([@bib16]). This analysis identified 21 novel DMRs: eight of which are located in well-known imprinted regions (three of which are in the Prader-Willi/Angelman region), three are known to be imprinted in mice, and two appear in a cluster, a common phenomenon for imprinted genes ([@bib8]) ([Table 2](#tbl2){ref-type="table"}, permutation test, p value = 0.011). These clustered DMRs are of specific interest as they reside in the Neuroblastoma breakpoint family (*NBPF*), suggesting that parental imprinting may be involved in the acquisition of the disease. Eight novel DMRs appear in regions not previously suggested to be imprinted. This type of novel DMR had good sequencing coverage and showed high levels of consistency between different samples of the same cell type ([Table 2](#tbl2){ref-type="table"}, permutation test, p value = 0.0059, see [Experimental Procedures](#sec4){ref-type="sec"}). To link between DNA methylation and gene expression on a genome-wide scale, we performed RNA sequencing (RNA-seq) in two independent PgHiPSC lines and two normal HESC and HiPSC lines. Our experiment yielded highly reproducible results and deep coverage reads. Parthenogenetic cells lack the paternal genome and consequently PEGs are expected to show downregulation when compared to normal biparental cells. Interestingly, we could identify five differentially expressed genes between PgHiPSCs and normal PSCs within 200 kb of the novel DMRs, strengthening the notion that they are potentially novel imprinted genes ([Figure S2](#app2){ref-type="sec"}F). Notably, of our 21 novel imprinted DMRs ([Figure S3](#app2){ref-type="sec"}) five are in the Prader-Willi/Angelman region, two of which are located in the promoters of known PEGs (*NDN* and *MAGEL2*) and are considered secondary DMRs, resulting from the maternal gDMRs in this region, and three are novel DMRs residing in yet-uncharacterized regions of this locus ([Figure S4](#app2){ref-type="sec"}A). As the complex phenotypes in both Prader-Willi and Angelman patients are still poorly understood ([@bib17]), it will be of great interest to analyze the status of these DMRs in patients.

Characterization of Imprinted DMRs Identifies a Novel Class of Intergenic DMRs {#sec2.3}
------------------------------------------------------------------------------

The transcription factor *CTCF* is a known regulator of several imprinted loci ([@bib2]; [@bib3]; [@bib11]). Intriguingly, when we analyzed chromatin immunoprecipitation sequencing (ChIP-seq) results of CTCF binding sites in HESCs ([@bib7]), we could identify significant enrichments (p value \< 1 × 10^−5^) for CTCF binding sites in proximity to many of the novel DMRs (15/21, [Figures 2](#fig2){ref-type="fig"}A and [S3](#app2){ref-type="sec"}), but could not find this enrichment for other pluripotent transcription factors. Using locus-specific bisulfite sequencing, we confirmed two of the novel DMRs, *WHAMMP3* and *TAPPC9*, as paternal and maternal DMRs, respectively ([Figure 2](#fig2){ref-type="fig"}B). Studying the stability of the novel imprinted DMRs in different cell types identified that all of the novel DMRs show striking similarities in methylation levels between HESCs and HiPSCs, but differ significantly from the PgHiPSCs ([Figures 2](#fig2){ref-type="fig"}C and 2D). Moreover, the vast majority of the novel DMRs are highly stable in both the undifferentiated and differentiated state ([Figure 2](#fig2){ref-type="fig"}E). A notable exception is the newly identified DMR in the *L3MBTL* locus, which similarly to *DIRAS3* and *PEG3* shows loss of imprinting following in vitro differentiation ([Figure 2](#fig2){ref-type="fig"}E). We next aimed to globally examine the properties of all imprinted DMRs identified in this study (n = 43). Plotting the chromosomal distribution of all imprinted DMRs elucidates that only a few chromosomes lack parental imprinting marks in humans ([Figure 3](#fig3){ref-type="fig"}A). The distribution of DMRs suggests that there are four genomic clusters of imprinted DMRs (*IGF2-H19*, *DLK1-DIO3*, *SNURF-SNRPN*, and *GNAS* loci), which probably result from differential gene expression (secondary DMRs) originating from the gDMRs in these loci. Two clusters (chromosomes 11 and 15) are marked by both paternal and maternal DMRs, while the two other clusters (chromosomes 14 and 20) are either complete maternal or paternal. Close examination of all imprinted DMRs ([Figure 3](#fig3){ref-type="fig"}B) shows that approximately 20% of all DMRs are not associated with genes (intragenic regions) or gene promoters and are located in intergenic region (\>4 kb of any nearby gene), a significant enrichment to the previously identified group of DMRs ([Figure S4](#app2){ref-type="sec"}B). Studying the distance between the intergenic DMRs to their nearest gene reveals that, unlike the previously identified DMRs ([Figure S4](#app2){ref-type="sec"}C), some intergenic DMRs are located as far as 10 kb from their nearest genes ([Figure 3](#fig3){ref-type="fig"}C). Moreover, the vast majority of the intergenic DMRs that reside in gene-poor regions are of paternal origin (pDMRs, [Figure 3](#fig3){ref-type="fig"}D), which is in agreement with previous reports ([@bib1]). To link gene expression and DNA methylation at imprinted DMRs, we analyzed our RNA-seq data and compared between normal PSCs and PgHiPSCs. First, we focused on promoter and intragenic DMRs. This class of imprinted DMRs are predicted to regulate the expression of their nearby genes. However, as some imprinted DMRs were previously shown to affect genes in cluster (e.g., *SNRPN* intron-2 DMR), we included all genes that are within 200 kb from the DMRs. Comparing this group of genes to that of all expressed genes in PSCs shows that most genes that are associated with imprinted DMRs are downregulated in the PgHiPSCs ([Figure 3](#fig3){ref-type="fig"}E; [Table S1](#app2){ref-type="sec"}). However, few known PEGs (e.g., *INPP5F*, *GRB10*, and *MEST*), and some putative imprinted genes identified in this study, are expressed at high levels in the PgHiPSCs ([Table S1](#app2){ref-type="sec"}), while their associate imprinted DMR is hypermethylated. This suggests that some of the putative imprinted genes are tissue specific and will start to be expressed from only one of the two parental alleles at a later stage in development ([@bib9]). It was recently shown that DNA methylation in intragenic regions may serve as alternative promoters in a tissue-specific manner ([@bib18]); it will thus be of interest to study the monoallelic expression of these putative imprinted genes in different adult tissues. We next examined the group of novel intergenic imprinted DMRs that are located more than 10 kb from the nearest gene ([Table S2](#app2){ref-type="sec"}). Here, we expanded our gene-expression analysis to include genes that are within 1 Mb of the DMR, in order to allow the discovery of long-range regulatory effects. Surprisingly, none of the novel intergenic DMRs had any effect on gene expression in PSCs ([Figure 3](#fig3){ref-type="fig"}F; [Table S2](#app2){ref-type="sec"}) and thus could be classified as a novel class of intergenic imprinted DMRs. Altogether, our gene-expression analysis in the pluripotent state could document only few novel imprinted genes, suggesting that some of the novel DMRs may regulate other processes beside gene expression or are regulated in a tissue-specific manner.

Comprehensive Comparison between Mouse and Human Imprinted DMRs {#sec2.4}
---------------------------------------------------------------

Mice serve as a good model for studying parental imprinting in humans. We therefore aimed to conduct a comprehensive comparison between mouse and human imprinted DMRs. We first examined mouse DMRs that were systematically identified in previous studies, focusing on DMRs that share synteny between mouse and human genomes and had sufficient coverage of reads in our cells. We also studied the corresponding genomic organization of mouse DMRs in which synteny was partial or not present in the human genome in order to identify putative human DMRs. Our data suggest that more than a third of the previously identified mouse imprinted DMRs do not have an equivalent DMR in the human genome ([Figure 4](#fig4){ref-type="fig"}A; [Table S3](#app2){ref-type="sec"}). We next took advantage of a recently established single-base resolution analysis of DNA methylation in the mouse ([@bib33]), to compare between mouse novel imprinted DMRs and the DMRs identified in our study. Strikingly, our analysis shows almost half of all imprinted DMRs are species specific ([Figure 4](#fig4){ref-type="fig"}B; [Table S3](#app2){ref-type="sec"}). Genomic synteny analysis shows that some of the mouse-specific imprinted DMRs, such as *Commd1/Zrsr1* DMR, lack a syntenic region in humans ([Figure 4](#fig4){ref-type="fig"}C). Since most of the studies so far were conducted in mouse, only four human-specific DMRs were identified to date. In this study, we could add 17 novel human-specific DMRs. Close examination of the data reveals that some of these DMRs may have acquired the imprint after diverging from the mouse and human common ancestor, as they share synteny with regions in which imprinted DMR was not identified in the mouse ([Figure 4](#fig4){ref-type="fig"}D).

Discussion {#sec3}
==========

In this study, we identified altogether 21 novel imprinted DMRs, including a novel class of intergenic DMRs, which reside in regions with no apparent imprinted genes in PSCs. This class of imprinted DMRs either may regulate genes in a tissue-specific manner, thus adding to the complexity of parental regulation in the adult tissues, or these parental marks regulate genes that are yet to be discovered. Notably, both *WHAMMP3* and *LOC100289656*, intergenic pDMRs in the Prader-Willi/Angelman region, are located in close proximity to a cluster of piRNAs. This class of regulatory small noncoding RNAs was previously linked with parental imprinting ([@bib32]), and thus it is attractive to suggest that this specific cluster of genes is expressed in a monoallelic fashion. The previously identified complex three-dimensional organization of the genome ([@bib15]) also suggests that this class of intergenic DMRs may interact with genes located in remote regions, thus regulating them in *trans*. Alternatively, it is plausible that this novel class of intergenic DMRs regulates other processes beside gene expression. As it was previously suggested, parental imprinting may be involved in marking the parental genomes for recombination ([@bib23]). It will thus be of great interest to study whether these intergenic DMRs may serve as hot spots for genetic processes such as recombination. The use of mouse model systems has greatly enhanced our understanding of parental imprinting. Yet, some genes that are imprinted in the mouse are not imprinted in the human orthologous gene ([@bib1]). Moreover, some mouse models fail to recapitulate phenotypes associated with human-imprinted syndromes ([@bib17]). Strikingly, our data imply that more than 50% of mouse- and human-imprinted DMRs are species specific. In addition, some of these DMRs (e.g., *WHAMMP3* and *LOC100289656*) reside in loci, which are associated with known human diseases such as Prader-Willi and Angelman syndromes. Therefore, our results emphasize the importance of studying imprinted DMRs in human. In addition, our analysis identified that several imprinted DMRs are consistently perturbed in HESCs and HiPSCs and thus should be carefully evaluated if these cells are to be used for clinical applications. Furthermore, as loss of imprinting was correlated before with different types of cancers, it will be worthy to study the differential methylation status of both previously identified and novel imprinted DMRs in tumor cell types.

The genomic coverage of RRBS is ∼10%; however, it covers the majority of CpG islands (CGIs) and promoters in the human genome ([@bib12]). As the vast majority of previously identified imprinted DMRs reside in CGIs and promoters (82%, [Figure S4](#app2){ref-type="sec"}D), our methodology is highly informative for identifying novel imprinted DMRs throughout the human genome. Future studies, using whole genome single-base resolution analysis of DNA methylation, will elucidate whether additional imprinted DMRs are also present in CpG-poor regions. In conclusion, we conducted a comprehensive analysis of imprinted DMRs in humans, identifying multiple novel DMRs, many of them not associated with gene expression. Our data shed light on the extent of the phenomenon of parental imprinting, suggesting that it may play a more extensive role than was previously thought.

Experimental Procedures {#sec4}
=======================

Genomic DNA Isolation {#sec4.1}
---------------------

Total genomic DNA was extracted from the parthenogenetic iPS and teratoma cells using genomic DNA extraction kit (Real Biotech Corporation) according to the manufacturer's protocol.

Reduced Representation Bisulfite Sequencing {#sec4.2}
-------------------------------------------

Reduced representation bisulfite sequencing libraries were generated as previously described in [@bib10]. Raw data were analyzed using the bioinformatic pipeline described in [@bib4].

Bioinformatic Analysis {#sec4.3}
----------------------

To identify novel imprinted DMRs throughout the genome, we searched for hemimethylated regions in both HESCs and HiPSCs and compared them to the methylation values of the parthenogenetic samples (difference between PgHiPSCs and HESCs was \>0.2). A series of filters was implied in order to avoid false-positive hits. Specifically, only regions that exhibited low variation between all CpGs (SD \< 0.2 in at least 60% of the samples for each cell type) were considered. Further filtering was performed by verifying high levels of consistency between the samples in each group (SD for average regional methylation value \<0.2). Next, in order to rule out false DMRs created by aberrant reprogramming ([@bib16]), all regions in which there was no agreement between PgHiPSCs and their parental fibroblasts (difference between parthenogenetic and teratoma \<0.2) were filtered out. Next, a more stringent approach was used in order to confidently identify imprinted DMRs in previously unknown imprinted regions. Thus, in addition to the above-mentioned criteria only regions with more than four shared CpGs and with minimal coverage of five reads among all samples were used in this study. As imprinted DMRs are maintained throughout the development of the embryo, we also looked for hemimethylated regions in normal fibroblasts. Finally, we included only regions that met the following criteria: (1) methylation difference between PgHiPSCs and HESCs \>0.2; (2) methylation difference between PgHiPSCs and HiPSCs \>0.15; and (3) methylation difference between parthenogenetic teratomas and normal fibroblasts \>0.15.

Statistical Analysis {#sec4.4}
--------------------

In order to faithfully identify DMRs, all reduced representation bisulfite sequencing (RRBS) regions with missing values were removed. In addition, as X inactivation results in large-scale differential methylation between the active and inactive X chromosomes both sex chromosomes were removed from the analysis, leaving 235,080 informative regions. Statistical significance of the identified DMRs was assessed by random permutations of samples between groups and recalculation of the average methylation and statistical values for each region. Permutated data sets were subject to the same criteria used to identify the DMRs and were generated until 20 random data sets gave at least the same number of DMRs as the original data set. p value was calculated as the probability of receiving the same number of hits in random data sets.

PCR Bisulfite Sequencing {#sec4.5}
------------------------

Genomic DNA (2 μg) was bisulfite-converted using EZ DNA methylation-Gold kit (Zymo Research), according to the manufacturer's instructions. PCRs were performed using Faststart Taq DNA polymerase (Roche) using primers designed to amplify suspected DMRs. Following amplification, PCR products were cleaned using Gel/PCR DNA fragments extraction kit (Geneaid) and ligated into pGEM T-Easy vector (Promega) and transformed into DH5α bacteria subjected to white/blue screen. Positive colonies were picked, and plasmid DNA was extracted for sequencing using Geneaid high-speed plasmid mini kit (New Taipei City, Taiwan). For a full list of primers, see primer list in [Table 3](#tbl3){ref-type="table"}.

High-Throughput Sequencing {#sec4.6}
--------------------------

Total RNA was extracted using MirVana microRNA isolation kit (Ambion Inc) according to the manufacturer's protocol. Complementary DNA libraries were established following ribosomal RNA (rRNA) depletion (RiboMinus Invitrogen). The SOLiD (version 3.5) sequencing system (Life Technologies) was used to generate 35-bp-long reads. Following barcode matching of the samples, reads were aligned to UCSC complete build (GRCh37/hg19) genome. All sequences that matched RNA contaminants such as transfer RNA, rRNA, and DNA repeats were subsequently filtered. Reads for each transcript was calculated in RPKM (reads per kilobase of exon model per million mapped reads) units, to obtain normalization of the number of reads relative to their transcript length.

Accession Numbers {#app4}
=================

The GEO accession number for the RRBS data reported in this paper is [GSE47088](ncbi-geo:GSE47088){#intref1015}.
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![Genome-wide Analysis of Imprinted DMRs in PSCs\
(A) Box-plot analysis showing distribution of DNA methylation in 20 HESCs lines in known imprinted DMRs. DMRs are ordered according to the levels of heterogeneity (x axis).\
(B--D) Average methylation calls ± SE of different cell types in known imprinted DMRs. DMRs are ordered by chromosome numbers (x axis); small arrows pointing to DMRs that are perturbed in the different cell types.\
(E and F) Regional view of *KCNQ1* and *H19* known DMR. Average methylation values for wild-type PSCs (blue) and PgHiPSCs (red) of all CpG calls. Green track indicates the difference between hemimethylated (AMC between 0.3 and 0.7) wild-type PSCs and PgHiPSCs CpGs. Shown are significant putative CTCF binding sites in H1 ES cells from the ENCODE project (depicted in black rectangles, p value \< 1 × 10^−5^) and CpG islands (UCSC) in dark-blue rectangles.\
See also [Figures S1](#app2){ref-type="sec"} and [S2](#app2){ref-type="sec"}.](gr1){#fig1}

![Genome-wide Analysis of Imprinted DMRs in PSCs\
(A) Regional view of two representative new DMR, *TRAPPC9* and *WHAMMP3*. Average methylation values for wild-type HESCs (blue) and PgHiPSCs (red) of all CpG calls. Green track indicates the difference between hemimethylated (AMC between 0.3 and 0.7) wild-type PSCs and PgHiPSCs CpGs. Shown are significant putative CTCF binding sites in H1 ES cells from the ENCODE project (depicted in black rectangles, p value \< 1 × 10^−5^) and CpG islands (UCSC) in dark-green rectangles. See also [Figure S3](#app2){ref-type="sec"}.\
(B) Bisulfite sequencing validation of pDMR (*WHAMMP3*, upper panel) and mDMR (*TRAPPC9*, lower panel) was conducted on normal independent PSC not included in the original analysis and PgHiPSCs lines.\
(C--E) Methylation values (y axis) ± SE in various cell types across the different imprinted DMRs *(*x axis); small arrows pointing to DMRs that are perturbed in the different cell types. (C) Comparison between HESCs and HiPSCs demonstrate the striking similarities between the two cell types. (D) Comparison between HESCs and the PgHiPSCs showing the differences between the two cell types in methylation values, as the PgHiPSCs are either hypermethylated (AMC \>0.7) or hypomethylated (AMC \<0.3) in comparison to hemimethylation state (AMC between 0.3 and 0.7) of the biparental cells. (E) Analysis of methylation in 16-day-old EBs differentiated from HESCs, demonstrating that the newly identified imprinted DMRs are highly stable following in vitro differentiation. Notable exception is the DMR in the *L3MBTL* locus, which is consistently hypomethylated in the differentiated cells.](gr2){#fig2}

![Characterization of Imprinted DMRs Identified in This Study\
(A) Chromosomal distribution of the 43 imprinted DMRs.\
(B) Pie chart representing the different genomic properties of all imprinted DMRs.\
(C) Distribution of distances of the imprinted intergenic DMRs to their nearest gene.\
(D) Percentage of maternal and paternal DMRs; all DMRs identified (left bar) and the subset of intergenic DMRs (right panel).\
(E and F) Distribution of expression ratios between normal PSCs and PgHiPSCs; x axes represent the log2 fold change between normal PSCs and PgHiPSCs, and y axes represent the distribution of frequencies for each of the samples; values for individual genes are represented by small vertical lines on the x axes; Verticals segmented red lines represent 2-fold in expression ratio. (E) Blue, genes associated with intragenic mDMRs (n = 64); black, all expressed genes (\>30 reads, n = 13,223). See also [Table S1](#app2){ref-type="sec"}. (F) Orange, genes associated with intergenic DMRs (\>10 kb from the nearest gene, n = 23); black, all expressed genes.\
See also [Figure S4](#app2){ref-type="sec"} and [Table S2](#app2){ref-type="sec"}.](gr3){#fig3}

![Synteny Analysis between Mouse and Human Imprinted DMRs\
(A) DNA methylation analysis of previously identified mouse DMRs in human syntenic regions. See also [Table S3](#app2){ref-type="sec"}.\
(B) Vann diagram demonstrating species-specific imprinted DMRs in known DMRs (upper panel), and in novel DMRs (lower panel) identified either by [@bib33] (left subset) or in our study (right subset). Bottom numbers represent the number of species-specific DMRs (left and right) and shared DMRs among species. See also [Table S3](#app2){ref-type="sec"}.\
(C and D) (C) Synteny analysis of mouse-specific DMR in the *Commd1/Zrsr1*, and (D) the human-specific DMRs *WHAMMP3* and *LOC100289656* that resides in the Prader-Willi/Angelman region.](gr4){#fig4}

###### 

Analysis of Previously Identified Human Imprinted DMRs

  Chromosome   Locus             CGI   Diff (ES-PG)   Parent of Origin
  ------------ ----------------- ----- -------------- ------------------
  chr1         DIRAS3            Yes   0.12           M
  chr2         ZDBF2             Yes   0.22           P
  chr6         PLAGL1            No    0.20           M
  chr7         GRB10             Yes   0.29           M
  chr7         PEG10/SGCE        No    0.51           M
  chr7         MEST              Yes   0.27           M
  chr10        INPP5F            Yes   0.25           M
  chr11        H19               Yes   0.21           P
  chr11        H19 -- ICR        Yes   0.38           P
  chr11        IGF2 DMR1         No    0.12           P
  chr11        KCNQ1OT1          Yes   0.23           M
  chr14        MEG3              No    0.35           P
  chr15        AS-ICR            Yes   0.48           M
  chr15        SNURF-SNRPN       Yes   0.47           M
  chr16        NAT15,ZNF597      Yes   0.30           P
  chr19        PEG3              Yes   0.14           M
  chr20        BLCAP,NNAT        Yes   0.16           M
  chr20        L3MBTL            Yes   0.23           M
  chr20        GNASXL            Yes   0.19           M
  chr20        NESPAS            No    0.57           M
  chr20        GNAS1A            Yes   0.21           M
  chr20        GNAS1A - exon 1   No    0.13           M

List of previously identified imprinted DMRs. CGI, CpG island; M, maternal; P, paternal. See also [Figure S3](#app2){ref-type="sec"}.

###### 

Human Imprinted DMRs Identified in This Study

                                    Chromosome      Locus      CGI    Diff   Parent of Origin   Differential Gene Expression
  --------------------------------- --------------- ---------- ------ ------ ------------------ ------------------------------
  DMRs in known imprinted regions   chr11           TH,ASCL2   Yes    0.45   P                  Yes
  chr14                             DIO3            Yes        0.31   P      No                 
  chr15                             WHAMMP3,NIPA1   Yes        0.23   P      No                 
  chr15                             PWRN2           Yes        0.23   P      No                 
  chr15                             LOC100289656    Yes        0.27   P      No                 
  chr16                             FLYWCH1         Yes        0.23   M      Yes                
  chr20                             L3MBTL          No         0.26   M      No                 
  chr20                             GNAS            Yes        0.27   M      No                 
  DMRs syntenic to mouse            chr8            TRAPPC9    Yes    0.30   M                  No
  chr15                             NDN             Yes        0.22   M      Yes                
  chr15                             MAGEL2          Yes        0.37   M      Yes                
  DMRs in clusters                  chr1            NBPF       Yes    0.20   P                  No
  chr1                              NBPF            Yes        0.29   P      No                 
  DMRs in unknown regions           chr1            TMEM51     Yes    0.38   M                  Yes
  chr5                              TSPAN17,UNC5A   Yes        0.51   P      No                 
  chr7                              TMEM176A/ B     No         0.30   P      Yes                
  chr9                              RCL1            Yes        0.41   P      No                 
  chr9                              ZNF322B         Yes        0.31   M      No                 
  chr10                             INPP5A          Yes        0.22   M      Yes                
  chr13                             TSC22D1         No         0.31   M      No                 
  chr17                             MIR301A         No         0.43   M      Yes                

List of new imprinted DMRs identified in this study. CGI, CpG island; M, maternal; P, paternal; Diff, difference in DNA methylation values between normal HESCs and PgHiPSCs. Differential gene expression was calculated according to the ratio in RPKM (reads per kilobase of exon model per million mapped reads) between normal and parthenogenetic cell. Fold change \>2 is indicated.

###### 

Bisulfite Sequencing Primer List

                  DMR                      Forward Primer             Reverse Primer
  --------------- ------------------------ -------------------------- ----------------------
  Bisulfite Seq   *TRAPPC9*                GGTTTTAGTAGTATTAGGTA       AAACTCTTTACCCTATAAAT
  *WHAMMP3*       GAGATTTTATTTTAAGTATTTA   CTAAAACCCAACCCTACTTCTATC   

[^1]: These authors contributed equally to this work
